This study will investigate the effects of a fluid challenge on microcirculatory vessel perfusion and the glycocalyx thickness. It is hypothesized that infusion of crystalloid fluids in healthy subjects is associated with a volume-dependant…
ID
Bron
Verkorte titel
Aandoening
microcirculation
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Microcirculatory perfused vessel density (PVD) and perfused boundary region (PBR) measured using sublingual Capiscope imaging.
Achtergrond van het onderzoek
During anesthesia and surgery, patients receive fluids to maintain system hemodynamics and to compensate for blood loss. Inadequate fluid resuscitation in the intraoperative period may not only result in perioperative hypovolemia or postoperative fluid overload, but may also change the integrity of the vascular wall. Animal studies suggest that the glycocalyx serves as a competent barrier for water and colloids, but may also be damaged by fluid infusion. However, evidence for this phenomenon in patients is limited, which is mainly due to the lack of measurement devices. With the introduction of a novel technique for evaluation of microvascular changes it has recently become possible to study glycocalyx dimensions in patients. In the present study we will investigate the effects of a fluid challenge on microcirculatory vessel perfusion and the glycocalyx thickness in order to gain more insight in the effects of fluid therapy on microvascular perfusion and the perfused boundary region.
Doel van het onderzoek
This study will investigate the effects of a fluid challenge on microcirculatory vessel perfusion and the glycocalyx thickness.
It is hypothesized that infusion of crystalloid fluids in healthy subjects is associated with a volume-dependant reduction in microcirculatory perfused vessel density and an increase in perfused boundary region due to effects of cristalloid fluid loading.
Besides, an attenuation of cristalloid-induced alterations in microcirculatory perfused vessel density and perfused boundary region by colloid administration is hypothesized.
Onderzoeksopzet
Healthy volunteers: 2 hours study period Patients: duration of anesthesia
Onderzoeksproduct en/of interventie
Healthy volunteers:
Subjects are first exposed to a bolus of crystalloid fluid (300 ml), which is followed by a bolus of colloid fluid (gelofusine) (300 ml).
Before and after fluid administration, the microcirculatory perfused vessel density and perfused boundary region are monitored using sublingual Capiscope imaging.
Subjects are hemodynamically monitored using Nexfin continuous blood pressure measurements.
The study ends after the last sublingual microcirculatory measurement.
Patients:
Anesthetized patients who are exposed to 500 ml crystalloid or colloid fluids (gelofusine) are monitored using sublingual Capiscope imaging to gain insight in the relation between the fluid balance and microcirculatory perfusion.
Before and after fluid administration, the microcirculatory perfused vessel density and perfused boundary region are monitored using sublingual Capiscope imaging.
Subjects are hemodynamically monitored using Nexfin continuous blood pressure measurements.
The study ends after the surgical procedure has been completed.
Publiek
Christa Boer
De Boelelaan 1117
Amsterdam 1081 HV
The Netherlands
+31 (0)20 4443830
c.boer@vumc.nl
Wetenschappelijk
Christa Boer
De Boelelaan 1117
Amsterdam 1081 HV
The Netherlands
+31 (0)20 4443830
c.boer@vumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Healthy volunteers (n=19): Age 18-85 years, normal renal function, normal liver function
Patients (n=26) undergoing elective abdominal surgery under general anesthesia, age 18-85 years, normal renal function, normal liver function
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Healthy volunteers:
Peripheral edema
Cardiovascular disease (hypertension, myocardial ischemia, heart failure)
Allergy to gelatines
Use of antihypertensive, diuretics
Severe asthma
Patients:
Peripheral edema
Myocardial infarction, heart failure, renal replacement therapy
Use of diuretics
Previous chemotherapy
Diabetes mellitus I or II with use of anti-diabetic medication
User of steroids
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4315 |
NTR-old | NTR4468 |
Ander register | : ANES 2013/01 |